Biotech INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP) October 30, 2026
Biotech Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution October 30, 2026
Biotech Rigel Announces Conference Call and Webcast to Report Third Quarter 2026 Financial Results October 30, 2026
Biotech Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors October 30, 2026
Biotech BioMarin Enters Into Exclusive Worldwide License Agreement With GC Biopharma and Hanmi Pharm for Investigational Next-Generation Enzyme Replacement Therapy, Adding a Second Potential Treatment for Fabry Disease October 30, 2026
Biotech Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast October 30, 2026
Biotech NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC’s Phase 3 Development at NEALS 2026 October 30, 2026
Biotech PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results October 29, 2026
Biotech Biohaven Reports Recent Business Developments and Third Quarter 2026 Financial Results October 29, 2026